Pfizer Inc. (LON: 0Q1N)
London
· Delayed Price · Currency is GBP · Price in USD
26.25
0.00 (0.00%)
At close: Jan 22, 2025
Pfizer Revenue
Pfizer had revenue of $17.70B USD in the quarter ending September 29, 2024, with 31.20% growth. This brings the company's revenue in the last twelve months to $59.38B, down -14.29% year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, down -41.70%.
Revenue (ttm)
$59.38B
Revenue Growth
-14.29%
P/S Ratio
n/a
Revenue / Employee
$674.72K
Employees
88,000
Market Cap
119.68B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |